Literature DB >> 22821963

CD8+CD45RA+CCR7+FOXP3+ T cells with immunosuppressive properties: a novel subset of inducible human regulatory T cells.

Masakatsu Suzuki1, Ann L Jagger, Christine Konya, Yasuhiro Shimojima, Sergey Pryshchep, Jörg J Goronzy, Cornelia M Weyand.   

Abstract

CD8 T cells stimulated with a suboptimal dose of anti-CD3 Abs (100 pg/ml) in the presence of IL-15 retain a naive phenotype with expression of CD45RA, CD28, CD27, and CCR7 but acquire new functions and differentiate into immunosuppressive T cells. CD8+CCR7+ regulatory T cells (Tregs) express FOXP3 and prevent CD4 T cells from responding to TCR stimulation and entering the cell cycle. Naive CD4 T cells are more susceptible to inhibition than memory cells. The suppressive activity of CD8+CCR7+ Tregs is not mediated by IL-10, TGF-β, CTLA-4, CCL4, or adenosine and relies on interference with very early steps of the TCR signaling cascade. Specifically, CD8+CCR7+ Tregs prevent TCR-induced phosphorylation of ZAP70 and dampen the rise of intracellular calcium in CD4 T cells. The inducibility of CD8+CCR7+ Tregs is correlated with the age of the individual with PBLs of donors older than 60 y yielding low numbers of FOXP3(low) CD8 Tregs. Loss of CD8+CCR7+ Tregs in the elderly host may be of relevance in the aging immune system as immunosenescence is associated with a state of chronic smoldering inflammation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22821963      PMCID: PMC3424334          DOI: 10.4049/jimmunol.1200122

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  69 in total

1.  Antigen-specific splenic CD4+ and CD8+ regulatory T cells generated via the eye, suppress experimental autoimmune encephalomyelitis either at the priming or at the effector phase.

Authors:  Sourojit Bhowmick; Robert B Clark; Stefan Brocke; Robert E Cone
Journal:  Int Immunol       Date:  2011-01-27       Impact factor: 4.823

Review 2.  Two modes of immune suppression by Foxp3(+) regulatory T cells under inflammatory or non-inflammatory conditions.

Authors:  Tomoyuki Yamaguchi; James B Wing; Shimon Sakaguchi
Journal:  Semin Immunol       Date:  2011-11-03       Impact factor: 11.130

Review 3.  Developmental plasticity of Foxp3+ regulatory T cells.

Authors:  Shohei Hori
Journal:  Curr Opin Immunol       Date:  2010-09-09       Impact factor: 7.486

Review 4.  Regulatory T cells: history and perspective.

Authors:  Shimon Sakaguchi
Journal:  Methods Mol Biol       Date:  2011

5.  HLA-E-restricted regulatory CD8(+) T cells are involved in development and control of human autoimmune type 1 diabetes.

Authors:  Hong Jiang; Steve M Canfield; Mary P Gallagher; Hong H Jiang; Yihua Jiang; Zongyu Zheng; Leonard Chess
Journal:  J Clin Invest       Date:  2010-09-27       Impact factor: 14.808

Review 6.  CD8+ T cell differentiation in the aging immune system: until the last clone standing.

Authors:  Veit R Buchholz; Michael Neuenhahn; Dirk H Busch
Journal:  Curr Opin Immunol       Date:  2011-06-12       Impact factor: 7.486

Review 7.  CD8(+) T regulatory/suppressor cells and their relationships with autoreactivity and autoimmunity.

Authors:  Gilberto Filaci; Daniela Fenoglio; Francesco Indiveri
Journal:  Autoimmunity       Date:  2010-07-29       Impact factor: 2.815

Review 8.  T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells.

Authors:  Guoyan Cheng; Aixin Yu; Thomas R Malek
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

9.  CD8+ T regulatory cells express the Ly49 Class I MHC receptor and are defective in autoimmune prone B6-Yaa mice.

Authors:  Hye-Jung Kim; Xuan Wang; Soroosh Radfar; Thomas J Sproule; Derry C Roopenian; Harvey Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-13       Impact factor: 11.205

10.  A human memory T cell subset with stem cell-like properties.

Authors:  Luca Gattinoni; Enrico Lugli; Yun Ji; Zoltan Pos; Chrystal M Paulos; Máire F Quigley; Jorge R Almeida; Emma Gostick; Zhiya Yu; Carmine Carpenito; Ena Wang; Daniel C Douek; David A Price; Carl H June; Francesco M Marincola; Mario Roederer; Nicholas P Restifo
Journal:  Nat Med       Date:  2011-09-18       Impact factor: 53.440

View more
  41 in total

1.  Modulation of PD-L1 and CD8 Activity in Idiopathic and Infectious Chronic Inflammatory Conditions.

Authors:  Louisa Mezache; Cynthia Magro; Craig Hofmeister; Flavia Pichiorri; Douglas Sborov; Gerard J Nuovo
Journal:  Appl Immunohistochem Mol Morphol       Date:  2017-02

2.  Suppression of Murine Lupus by CD4+ and CD8+ Treg Cells Induced by T Cell-Targeted Nanoparticles Loaded With Interleukin-2 and Transforming Growth Factor β.

Authors:  David A Horwitz; Sean Bickerton; Michael Koss; Tarek M Fahmy; Antonio La Cava
Journal:  Arthritis Rheumatol       Date:  2019-03-05       Impact factor: 10.995

3.  Tregs in gliomas - the jury is still out.

Authors:  Michael Platten; Wolfgang Wick
Journal:  Neuro Oncol       Date:  2015-03-09       Impact factor: 12.300

4.  The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients.

Authors:  Kyoung Woon Kim; Byung Ha Chung; Bo-Mi Kim; Mi-La Cho; Chul Woo Yang
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

5.  Central memory CD8+ T lymphocytes mediate lung allograft acceptance.

Authors:  Alexander Sasha Krupnick; Xue Lin; Wenjun Li; Ryuiji Higashikubo; Bernd H Zinselmeyer; Hollyce Hartzler; Kelsey Toth; Jon H Ritter; Mikhail Y Berezin; Steven T Wang; Mark J Miller; Andrew E Gelman; Daniel Kreisel
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

6.  Working toward immune tolerance in lung transplantation.

Authors:  Xinguo Jiang; Mark R Nicolls
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

Review 7.  The immunoinhibitory PD-1/PD-L1 pathway in inflammatory blood vessel disease.

Authors:  Cornelia M Weyand; Gerald J Berry; Jörg J Goronzy
Journal:  J Leukoc Biol       Date:  2017-12-29       Impact factor: 4.962

Review 8.  Aging of the Immune System. Mechanisms and Therapeutic Targets.

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  Ann Am Thorac Soc       Date:  2016-12

9.  Therapeutic polyclonal human CD8+ CD25+ Fox3+ TNFR2+ PD-L1+ regulatory cells induced ex-vivo.

Authors:  David A Horwitz; Stephanie Pan; Jing-Ni Ou; Julie Wang; Maogen Chen; J Dixon Gray; Song Guo Zheng
Journal:  Clin Immunol       Date:  2013-08-20       Impact factor: 3.969

Review 10.  Regulatory T cells and the immune aging process: a mini-review.

Authors:  Ann Jagger; Yasuhiro Shimojima; Jorg J Goronzy; Cornelia M Weyand
Journal:  Gerontology       Date:  2013-11-28       Impact factor: 5.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.